U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864351) titled 'Prospective Evaluation of OptiThyDose' on March 03. Brief Summary: The aim of this multice... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864754) titled 'WashU DIEP Flap Video and Patient Understanding Improvement' on March 03. Brief Summary: P... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864598) titled 'The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance ... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863454) titled 'Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinic... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864611) titled 'Evaluating Huddles As a Novel Approach to Improving Concussion Safety' on Feb. 21. Brief S... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864260) titled 'Cancer Prevention Through Enhanced EnvironMent' on March 03. Brief Summary: The goal of Ca... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864429) titled 'Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle ... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865131) titled 'Efficacy Study with StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breas... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863831) titled 'A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Che... Read More
U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864182) titled 'Relative Bioavailability Study of CX2101A for the Treatment of COVID-19' on Feb. 24. Brief... Read More